AAAAAA

   
Results: 1-10 |
Results: 10
REDUCED GLUTATHIONE AND S-ACETYLGLUTATHIONE AS SELECTIVE APOPTOSIS-INDUCING AGENTS IN CANCER-THERAPY (VOL 110, PG 63, 1996)
Authors: DONNERSTAG B OHLENSCHLAGER G CINATL J AMRANI M HOFMANN D FLINDT S TREUSCH G TRAGER L
Citation: B. Donnerstag et al., REDUCED GLUTATHIONE AND S-ACETYLGLUTATHIONE AS SELECTIVE APOPTOSIS-INDUCING AGENTS IN CANCER-THERAPY (VOL 110, PG 63, 1996), Cancer letters, 115(2), 1997, pp. 265-265
USE OF ORAL ENZYMES IN MULTIPLE-SCLEROSIS - PHENOTYPING OF PERIPHERAL-BLOOD LYMPHOCYTES FROM MS PATIENTS UNDER LONG-TERM TREATMENT WITH ORALLY-ADMINISTERED HYDROLYTIC ENZYMES
Authors: STAUDER G DONNERSTAG B BAUMHACKL U BUSCHMANS E
Citation: G. Stauder et al., USE OF ORAL ENZYMES IN MULTIPLE-SCLEROSIS - PHENOTYPING OF PERIPHERAL-BLOOD LYMPHOCYTES FROM MS PATIENTS UNDER LONG-TERM TREATMENT WITH ORALLY-ADMINISTERED HYDROLYTIC ENZYMES, International journal of immunotherapy, 13(3-4), 1997, pp. 135-137
REDUCED GLUTATHIONE AND S-ACETYLGLUTATHIONE AS SELECTIVE APOPTOSIS-INDUCING AGENTS IN CANCER-THERAPY
Authors: DONNERSTAG B OHLENSCHLAGER G CINATL J AMRANI M HOFMANN D FLINDT S TREUSCH G TRAGER L
Citation: B. Donnerstag et al., REDUCED GLUTATHIONE AND S-ACETYLGLUTATHIONE AS SELECTIVE APOPTOSIS-INDUCING AGENTS IN CANCER-THERAPY, Cancer letters, 110(1-2), 1996, pp. 63-70
IMMUNOLOGICAL PROFILE OF PATIENTS WITH OVARIAN-CANCER UNDER IMMUNOSTIMULATION WITH MURINE MONOCLONAL-ANTIBODIES
Authors: DONNERSTAG B OLTROGGE JB BAUM RP SKIERLO M NIESEN A HOR G TRAGER L
Citation: B. Donnerstag et al., IMMUNOLOGICAL PROFILE OF PATIENTS WITH OVARIAN-CANCER UNDER IMMUNOSTIMULATION WITH MURINE MONOCLONAL-ANTIBODIES, International journal of oncology, 6(4), 1995, pp. 853-858
EVALUATION OF TUMOR-IMMUNITY IN PATIENTS WITH OVARIAN-CANCER AFTER IMMUNOSCINTIGRAPHY IN A LONG-TERM FOLLOW-UP
Authors: DONNERSTAG B BAUM RP OLTROGGE JB HENZEL K TRAGER L HOR G
Citation: B. Donnerstag et al., EVALUATION OF TUMOR-IMMUNITY IN PATIENTS WITH OVARIAN-CANCER AFTER IMMUNOSCINTIGRAPHY IN A LONG-TERM FOLLOW-UP, Hybridoma, 14(2), 1995, pp. 191-197
RELEVANCE OF IMMUNOLOGICAL PARAMETERS IN PROGRESSION OF COLORECTAL-CARCINOMA
Authors: DONNERSTAG B HENZEL K STAIBSEBLER E OLTROGGE JB LORENZ M TRAGER L
Citation: B. Donnerstag et al., RELEVANCE OF IMMUNOLOGICAL PARAMETERS IN PROGRESSION OF COLORECTAL-CARCINOMA, Oncology Reports, 1(2), 1994, pp. 419-422
ACTIVATING ANTIIDIOTYPIC HUMAN ANTI-MOUSE ANTIBODIES FOR IMMUNOTHERAPY OF OVARIAN-CARCINOMA
Authors: BAUM RP NIESEN A HERTEL A NANCY A HESS H DONNERSTAG B SYKES TR SYKES CJ SURESH MR NOUJAIM AA HOR G
Citation: Rp. Baum et al., ACTIVATING ANTIIDIOTYPIC HUMAN ANTI-MOUSE ANTIBODIES FOR IMMUNOTHERAPY OF OVARIAN-CARCINOMA, Cancer, 73(3), 1994, pp. 1121-1125
CYTOTOXICITY TUMOR-ASSOCIATED LYMPHOCYTES FROM ASCITES AND PLEURAL EXUDATE OF PATIENTS WITH OVARIAN OR BREAST-CANCER
Authors: SCHRODER W DONNERSTAG B LISSNER R BENDER HG
Citation: W. Schroder et al., CYTOTOXICITY TUMOR-ASSOCIATED LYMPHOCYTES FROM ASCITES AND PLEURAL EXUDATE OF PATIENTS WITH OVARIAN OR BREAST-CANCER, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 1102-1103
CLINICAL COURSE OF OVARIAN-CANCER PATIENTS UNDER REPEATED STIMULATIONOF HAMA USING MAB-OC125 AND B43.13
Authors: BAUM RP NOUJAIM AA NANCI A MOEBUS V HERTEL A NIESEN A DONNERSTAG B SYKES T BONIFACE G HOR G
Citation: Rp. Baum et al., CLINICAL COURSE OF OVARIAN-CANCER PATIENTS UNDER REPEATED STIMULATIONOF HAMA USING MAB-OC125 AND B43.13, Hybridoma, 12(5), 1993, pp. 583-589
INFLUENCE OF ANTIIDIOTYPIC HAMA ON 3 DIFFERENT TUMOR-MARKER ASSAYS INOVARIAN-CANCER PATIENTS
Authors: HERTEL A BAUM RP NANCY A SCHULTE L SURESH MR NOUJAIM AA DONNERSTAG B OLTROGGE J HOR G
Citation: A. Hertel et al., INFLUENCE OF ANTIIDIOTYPIC HAMA ON 3 DIFFERENT TUMOR-MARKER ASSAYS INOVARIAN-CANCER PATIENTS, The Journal of nuclear medicine, 34(5), 1993, pp. 126-126
Risultati: 1-10 |